Stocktoria
Rocket One Inc. RKTO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-02-15
Rocket One Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $5.9M | $3.2M | $3.7M | $4.9M | $7.4M |
| Operating income | -$12.4M | -$8.2M | -$8.0M | -$11.1M | -$14.1M |
| Net income | -$12.5M | -$8.2M | -$8.1M | -$11.4M | -$14.3M |
| EPS (diluted) | $-0.90 | $-1.28 | $-2.38 | $-9.50 | $-16.02 |
| Operating cash flow | -$9.8M | -$7.0M | -$8.4M | -$9.3M | -$12.1M |
| Cash & equivalents | $6.2M | $7.0M | $9.3M | $6.4M | $8.5M |
| Total assets | $7.6M | $7.7M | $10.2M | $7.7M | $11.0M |
| Total liabilities | $1.5M | $833,906 | $704,983 | $1.6M | $1.1M |
| Shareholders' equity | $6.2M | $6.9M | $9.5M | $6.1M | $9.9M |
Source: SEC EDGAR filings · CIK 0001711786 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.